0
Signin
countryflagUS

18889881171

MSFT 430.59 0.8407% AAPL 222.5 -0.1212% NVDA 119.1 -0.0336% GOOGL 157.46 1.7907% GOOG 158.37 1.8195% AMZN 186.49 -0.2727% META 524.62 -0.1865% AVGO 167.69 1.902% TSLA 230.29 0.2089% TSM 172.5 0.6242% LLY 923.71 -1.2096% V 287.35 0.6938% JPM 204.32 -1.1036% UNH 594.32 1.0027% NVO 137.0 0.2488% WMT 80.6 1.18% LVMUY 134.665 -0.226% XOM 111.15 -0.0719% LVMHF 675.14 0.1691% MA 493.36 0.254%

Aesthetic Medical Intl Holding Ltd

Healthcare US AIH

NoneUSD
-(-%)

Last update at 2024-09-11T10:46:27.682245Z

Day Range

--
LowHigh

52 Week Range

0.121.43
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap15.93M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-6.68800M
  • Revenue TTM682.59M
  • Revenue Per Share TTM15.55
  • Gross Profit TTM 355.59M
  • Diluted EPS TTM-0.12

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -94.17300M -681.31400M -259.49200M 152.36M -233.97200M
Minority interest -0.14100M 82.90M 34.84M 43.12M 29.05M
Net income -76.10600M -669.51600M -246.90500M 136.31M -255.23700M
Selling general administrative 150.38M 206.97M 230.65M 196.33M 115.48M
Selling and marketing expenses 226.47M 404.68M 510.61M 413.07M 333.53M
Gross profit 355.59M 269.50M 544.78M 593.10M 502.74M
Reconciled depreciation 61.49M 99.14M 106.41M 83.83M 32.14M
Ebit -72.53800M -340.12500M -303.73900M 93.54M -224.42700M
Ebitda -11.05200M -240.99000M -197.33400M 177.37M -192.28700M
Depreciation and amortization 61.49M 99.14M 106.41M 83.83M 32.14M
Non operating income net other - - - 0.00000M 0.00000M
Operating income -72.53800M -340.12500M -303.73900M 93.54M -227.48500M
Other operating expenses 691.36M 987.75M 1098.05M 885.35M 707.58M
Interest expense 21.64M 27.23M 29.19M 23.91M 9.24M
Tax provision -18.06700M -11.79800M -12.58700M 14.04M 18.51M
Interest income 0.15M 0.11M 1.19M 0.39M 0.32M
Net interest income -21.48000M -27.11700M -28.00400M -23.90500M -8.92200M
Extraordinary items - - - 0.00000M 0.00000M
Non recurring - - - 0.00000M 0.00000M
Other items - - - 0.00000M 0.00000M
Income tax expense -18.06700M -11.79800M -12.58700M 14.04M 18.51M
Total revenue 670.09M 645.59M 901.57M 869.05M 761.31M
Total operating expenses 376.85M 611.65M 741.25M 609.40M 449.01M
Cost of revenue 314.50M 376.09M 356.80M 275.95M 258.57M
Total other income expense net -21.63500M -341.18900M 44.25M 58.83M -278.77800M
Discontinued operations - - - 0.00000M 0.00000M
Net income from continuing ops -76.10600M -669.51600M -246.90500M 138.33M -252.48000M
Net income applicable to common shares -76.24700M -586.61900M -235.47900M 136.31M -255.23700M
Preferred stock and other adjustments - - - 0.00000M 0.00000M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 560.66M 546.37M 576.94M 1038.09M 1047.13M
Intangible assets 3.88M 4.27M -17.15100M 46.90M 60.24M
Earning assets - - - - -
Other current assets 23.81M 0.29M 0.29M 8.71M 110.20M
Total liab 527.03M 672.25M 763.36M 612.35M 456.54M
Total stockholder equity 48.89M -113.65800M -156.66700M 390.90M 547.48M
Deferred long term liab - - - - 0.00000M
Other current liab 47.03M 62.68M 89.44M 87.71M 79.01M
Common stock 0.98M 0.63M 0.47M 0.47M 0.47M
Capital stock 0.98M 0.63M 0.47M 0.47M 0.47M
Retained earnings -1178.20300M -1140.77100M -1064.52400M -477.90500M -242.23200M
Other liab - - 0.28M 21.56M 12.70M
Good will 33.00M 33.00M 54.39M 161.53M 115.18M
Other assets - 109.53M 62.34M 83.22M 77.44M
Cash 62.34M 12.16M 39.29M 44.38M 154.49M
Cash and equivalents - - - - -
Total current liabilities 411.38M 543.84M 541.66M 301.69M 265.30M
Current deferred revenue 193.04M 169.72M 236.48M 8.64M 5.54M
Net debt 182.21M 380.94M 366.62M 416.40M 187.78M
Short term debt 128.90M 264.68M 184.49M 171.68M 163.74M
Short long term debt 93.44M 237.33M 156.21M 135.81M 127.47M
Short long term debt total 244.55M 393.10M 405.91M 460.79M 342.27M
Other stockholder equity -2.02300M -2.02300M -2.02300M -2.02300M -0.04100M
Property plant equipment - 320.82M 358.75M 531.94M 519.32M
Total current assets 111.57M 77.60M 113.71M 206.16M 264.69M
Long term investments 0.00000M 1.16M 4.90M 8.33M 10.26M
Net tangible assets - -150.92800M -193.90500M 182.47M 372.06M
Short term investments 19.65M - - - 11.21M
Net receivables 12.92M 10.53M 43.85M 119.73M 84.08M
Long term debt 31.41M 29.11M 115.67M 110.12M 12.92M
Inventory 15.58M 27.85M 30.57M 33.34M 26.12M
Accounts payable 42.40M 46.75M 31.26M 33.65M 17.02M
Total permanent equity - - - - 0.00000M
Noncontrolling interest in consolidated entity - - - - 0.00000M
Temporary equity redeemable noncontrolling interests - - - - 0.00000M
Accumulated other comprehensive income 1228.13M 1028.51M 909.41M 870.36M 789.28M
Additional paid in capital - - - - 0.00000M
Common stock total equity - - - 0.47M 0.47M
Preferred stock total equity - - - - 0.00000M
Retained earnings total equity - - - - 0.00000M
Treasury stock - - - - 0.00000M
Accumulated amortization - - - - 0.00000M
Non currrent assets other 108.00M 48.36M 16.57M 51.85M 57.67M
Deferred long term asset charges - - - - 0.00000M
Non current assets total 449.10M 468.77M 463.23M 831.92M 782.44M
Capital lease obligations 119.70M 126.66M 134.03M 214.85M 201.88M
Long term debt total - - - - 0.00000M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 3.11M -11.52500M -21.28700M -114.17200M -76.18200M
Change to liabilities -50.33400M 232.70M 2.82M -1.87100M -2.22700M
Total cashflows from investing activities 3.11M -11.52500M -127.36800M -114.17200M -76.18200M
Net borrowings -33.74500M -31.29200M 31.16M -89.58200M 50.74M
Total cash from financing activities 45.55M -45.23500M 17.70M 79.56M 66.74M
Change to operating activities -102.71700M -17.91000M 25.66M -16.26300M -64.74100M
Net income -94.17300M -681.31400M -259.49200M 152.36M -233.97200M
Change in cash -27.12800M -5.09500M -110.10600M 52.60M -3.45900M
Begin period cash flow 39.29M 44.38M 154.49M 101.89M 106.01M
End period cash flow 12.16M 39.29M 44.38M 154.49M 102.55M
Total cash from operating activities -75.12600M 51.09M -0.84300M 86.76M 4.89M
Issuance of capital stock 94.15M 0.00000M 0.00000M 181.91M 25.70M
Depreciation 61.49M 99.14M 106.41M 83.83M 32.14M
Other cashflows from investing activities -4.08200M 30.38M -10.97300M 13.54M 3.55M
Dividends paid 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change to inventory -0.29400M -0.80000M -8.97100M -3.03700M 3.40M
Change to account receivables 1.30M 3.85M -7.78100M 1.38M -0.82400M
Sale purchase of stock 0.00000M 0.00000M -1.98200M 181.91M 25.70M
Other cashflows from financing activities 261.46M 226.96M 300.92M 127.00M 98.92M
Change to netincome 91.68M 316.78M 115.82M -113.58700M 292.39M
Capital expenditures 1.68M 33.44M 45.16M 76.00M 46.25M
Change receivables - - - 0.00000M 0.00000M
Cash flows other operating - - - 0.00000M 0.00000M
Exchange rate changes - - - 0.00000M 0.00000M
Cash and cash equivalents changes - - - 0.00000M 0.00000M
Change in working capital -152.04300M 217.84M 11.73M -19.79500M -64.39700M
Stock based compensation 27.53M 35.46M 78.97M 47.79M -
Other non cash items 82.08M 29.83M 30.28M -152.83200M 271.12M
Free cash flow -76.80400M 17.65M -46.00500M 10.76M -41.35500M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AIH
Aesthetic Medical Intl Holding Ltd		 - -% - - 18.55 0.03 3.27 0.08 -0.5439
HCA
HCA Holdings Inc		 3.01 0.77% 394.68 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR		 0.23 2.45% 9.61 16.87 9.44 0.42 0.78 0.79 5.37
FSNUF
Fresenius SE & Co. KGaA		 - -% 37.08 16.76 9.62 0.42 0.79 0.78 5.31
JDHIY
JD Health International Inc		 - -% 3.20 62.50 35.97 0.30 2.32 0.16 3.90

Reports Covered

Stock Research & News

View All

Profile

Aesthetic Medical International Holdings Group Limited provides aesthetic medical services in the People's Republic of China and Singapore. The company offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments, including minimally invasive and energy-based treatments, which include laser, ultrasound, and radiofrequency treatments. It also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services. The company was founded in 1997 and is headquartered in Shenzhen, the People's Republic of China.

Aesthetic Medical Intl Holding Ltd

1122 Nanshan Boulevard, Shenzhen, China, 518052

Key Executives

Name Title Year Born
Dr. Pengwu Zhou Co-Founder, Chairman & CEO 1955
Ms. Ding Wenting Co-Founder, Vice-Chairwoman & Chief Marketing Officer 1967
Mr. Guanhua Wu Chief Financial Officer 1983
Ms. Qing Hu COO & Director 1963
Derrick Shi Investor Relations Associate Director NA
Dr. Yitao Zhou Chief Medical Technique Officer & Director 1978
Dr. Pengwu Zhou Co-Founder & Non-Executive Co-Chairman of the Board 1955
Mr. Chen Zhang Executive co-chairman of the Board NA
Ms. Ding Wenting Co-Founder & Chief Marketing Officer 1965
Ms. Qing Hu Chief Operating Officer 1964

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.